| 2015 |
Brachyury and SMAD signalling collaboratively orchestrate distinct mesoderm and endoderm gene regulatory networks in differentiating human embryonic stem cells.
|
Development |
Faial, T., Bernardo, AS., Mendjan, S., Diamanti, E., Ortmann, D., Gentsch, GE., Mascetti, VL., Trotter, MW., Smith, JC., Pedersen, RA. |
| 2015 |
Activin/nodal signaling and NANOG orchestrate human embryonic stem cell fate decisions by controlling the H3K4me3 chromatin mark.
|
Genes Dev |
Bertero, A., Madrigal, P., Galli, A., Hubner, NC., Moreno, I., Burks, D., Brown, S., Pedersen, RA., Gaffney, D., Mendjan, S., Pauklin, S., Vallier, L. |
| 2014 |
NANOG and CDX2 pattern distinct subtypes of human mesoderm during exit from pluripotency.
|
Cell Stem Cell |
Mendjan, S., Mascetti, VL., Ortmann, D., Ortiz, M., Karjosukarso, DW., Ng, Y., Moreau, T., Pedersen, RA. |
| 2012 |
Synthetic organs for regenerative medicine.
|
Cell Stem Cell |
Pedersen, RA., Mascetti, V., Mendjan, S. |
| 2012 |
Status of genomic imprinting in epigenetically distinct pluripotent stem cells.
|
Stem Cells |
Sun, B., Ito, M., Mendjan, S., Ito, Y., Brons, IG., Murrell, A., Vallier, L., Ferguson-Smith, AC., Pedersen, RA. |
| 2009 |
Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.
|
Development |
Vallier, L., Mendjan, S., Brown, S., Chng, Z., Teo, A., Smithers, LE., Trotter, MW., Cho, CH., Martinez, A., Rugg-Gunn, P., Brons, G., Pedersen, RA. |
| 2007 |
The right dose for every sex.
|
Chromosoma |
Mendjan, S., Akhtar, A. |
| 2006 |
Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila.
|
Mol Cell |
Mendjan, S., Taipale, M., Kind, J., Holz, H., Gebhardt, P., Schelder, M., Vermeulen, M., Buscaino, A., Duncan, K., Mueller, J., Wilm, M., Stunnenberg, HG., Saumweber, H., Akhtar, A. |
